New angionesis inhibitor ramucirumab: Extended overall survival in monotherapy and combination therapy

Translated title of the contribution: New angionesis inhibitor ramucirumab: Extended overall survival in monotherapy and combination therapy

Research output: Contribution to journal › Article › peer-review

Translated title of the contribution	New angionesis inhibitor ramucirumab: Extended overall survival in monotherapy and combination therapy
Original language	English
Pages (from-to)	31-39
Number of pages	9
Journal	Onkologe
Volume	20
Issue number	12
State	Published - 29 Nov 2014
Externally published	Yes

Cite this

@article{f9101dbf120b435a8f61a49b1ec31dd2,

title = "New angionesis inhibitor ramucirumab: Extended overall survival in monotherapy and combination therapy",

author = "S. Lorenzen",

year = "2014",

month = nov,

day = "29",

language = "English",

volume = "20",

pages = "31--39",

journal = "Onkologe",

issn = "0947-8965",

publisher = "Springer Verlag",

number = "12",

}

TY - JOUR

T1 - New angionesis inhibitor ramucirumab

T2 - Extended overall survival in monotherapy and combination therapy

AU - Lorenzen, S.

PY - 2014/11/29

Y1 - 2014/11/29

UR - http://www.scopus.com/inward/record.url?scp=84916944124&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84916944124

SN - 0947-8965

VL - 20

SP - 31

EP - 39

JO - Onkologe

JF - Onkologe

IS - 12

ER -